Medindia

X

Cardiac Science Signs Letter of Intent With Misys Healthcare Systems to Connect With Their EMR Systems

Tuesday, April 1, 2008 General News J E 4
Advertisement
BOTHELL, Wash., April 1, 2008 Cardiac Science(Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation,rehabilitation, and informatics products, announced today that it signed aletter of intent to begin establishing Heartcentrix(R) ECG connectivity withthe Misys MyWay(TM) electronic medical record (EMR) system from MisysHealthcare.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

Misys Healthcare serves more than 100,000 physicians in 18,000 practicelocations. "Misys MyWay integrates EMR, practice management, and claimsmanagement to offer a simple, affordable, complete solution for physicians andclinicians," Paul Edge, Vice President, Clinical Solutions for MisysHealthcare said. "With this agreement, thousands of our customers have thepotential to access information from new or currently installed Burdick andQuinton electrocardiograph (ECG) devices, stress systems, and Holter deviceswhile using our Misys MyWay EMR systems."

The HeartCentrix solution from Cardiac Science helps bring patienthistory, clinical charting, e-prescribing, lab orders, results, and patientfollow-up information together into a single EMR application. "We designedHeartCentrix to streamline diagnostic cardiology workflow," said Greg Newman,senior marketing manager for Cardiac Science. "Ultimately, the patientbenefits. With streamlined integration, physicians have easier access toinformation, faster results, and fewer chances for operator error, patientsreceive a higher standard of care."

Tony Titus, Cardiac Science vice president of marketing added, "Theagreement with Misys Healthcare is another step in our goal to connect ourdiagnostic cardiology products seamlessly with all major EMR solutionproviders. We're very much looking forward to this partnership."

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanceddiagnostic and therapeutic cardiology devices and systems, including automatedexternal defibrillators (AEDs), electrocardiograph devices (ECGs), cardiacstress systems and treadmills, Holter monitoring systems, hospitaldefibrillators, cardiac rehabilitation telemetry systems, and cardiology datamanagement systems (informatics) that connect with hospital information (HIS),electronic medical record (EMR), and other information systems. The Companysells a variety of related products and consumables, and provides a portfolioof training, maintenance, and support services. Cardiac Science, the successorto the cardiac businesses that established the trusted Burdick(R),HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered inBothell, Washington. With customers in more than 100 countries worldwide, thecompany has operations in North America, Europe, and Asia. For information,call 425.402.2000 or visit http://www.cardiacscience.com.

About Misys Healthcare Systems, LLC

Misys Healthcare -- part of the global application software and servicescompany, Misys plc (FTSE: MSY.L) -- delivers integrated, comprehensivesolutions that improve results for healthcare practitioners. Drawing on ourdecades of healthcare experience, our relationships with more than 100,000healthcare professionals, and our commitment to customer success, we deliverinnovative software and services that enable physicians, caregivers, and aconnected healthcare community. Misys Healthcare: Experience, Solutions,Results. Contact us today; visit http://www.misyshealthcare.com.

Forward Looking Statements

This press release contains forward-looking statements. These statementsand their underlying assumptions involve a number of risks and uncertaintiesand are not guarantees of future performance. These are forward-lookingstatements for purposes of the safe harbor provisions under the PrivateSecurities Litigation Reform Act of 1995. The words "believe," "expect,""intend,
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Neurobiological Technologies Appoints Matthew M. L...
S
Monogram Biosciences Provides Progenics Pharmaceut...